Details of the Drug Formulations

General Information of Drug (ID: DM0YWJC)

Drug Name
Safinamide Drug Info
Synonyms
133865-89-1; Xadago; (S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide; Fce-26743; UNII-90ENL74SIG; (2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl]methylamino]propanamide; EMD 1195686; 90ENL74SIG; CHEMBL396778; EMD-1195686; AK-77847; 2(s)-(4-(3-fluorobenzyloxy)benzylamino)propionamide; CHEMBL48582; Safinamide [USAN:INN]; 2-(4-(3-Fluorobenzyloxy)benzylamino)propionamide; AC1L2ZLK; Safinamide (USAN/INN); (S)-2-(((4-((3-Fluorophenyl)methoxy)phenyl)methyl)amino)propanamide; EC 603-772-2; SCHEMBL69350; Fce 26743; ON 019190.Na
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Approved [1]
Idiopathic parkinson disease 8A00.0Z Phase 3 [2] , [3]
Cross-matching ID
PubChem CID
131682
ChEBI ID
CHEBI:134718
CAS Number
133865-89-1
TTD ID
D0TV6I
VARIDT ID
DR00042
ACDINA ID
D00612

Full List of Drug Formulations Containing This Drug

Safinamide Mesylate 100 mg tablet
Company Formulation ID FDA Description
Mdd Us Operations F24312 Colloidal Silicon Dioxide; Crospovidone; Hypromellose; Iron Oxide (Red); Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol 6000; Potassium Aluminum Silicate; Titanium Dioxide
------------------------------------------------------------------------------------
Safinamide Mesylate 50 mgl tablet
Company Formulation ID FDA Description
Mdd Us Operations F24394 Colloidal Silicon Dioxide; Crospovidone; Hypromellose; Iron Oxide (Red); Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol 6000; Potassium Aluminum Silicate; Titanium Dioxide
------------------------------------------------------------------------------------
Safinamide 100 mg tablet
Company Formulation ID FDA Description
US WorldMeds F19712 Magnesium stearate; Ferric oxide red; Titanium dioxide; Polyethylene glycol 6000; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Mica; Microcrystalline cellulose
------------------------------------------------------------------------------------
Safinamide 50 mg tablet
Company Formulation ID FDA Description
US WorldMeds F19713 Magnesium stearate; Ferric oxide red; Titanium dioxide; Polyethylene glycol 6000; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Mica; Microcrystalline cellulose
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8291).
3 Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42.